The Landscape of LGBTQ+ Health Disparities in Diabetes

Diabetes affects more than 37 million Americans, yet the burden is not evenly distributed. Research consistently shows that LGBTQ+ individuals experience higher rates of type 2 diabetes compared to their cisgender, heterosexual peers. This disparity stems from a complex interplay of social determinants, including higher rates of poverty, food insecurity, and limited access to affirming healthcare. Moreover, LGBTQ+ patients often face unique pathophysiological factors. For example, transgender individuals using gender-affirming hormone therapy may experience changes in insulin sensitivity and glucose metabolism, requiring careful monitoring and adjustment of diabetes regimens.

Understanding these disparities is the first step toward meaningful change. Healthcare providers must move beyond a one-size-fits-all approach and embrace a framework that accounts for the lived experiences of LGBTQ+ patients. The American Diabetes Association (ADA) has recognized the need for inclusive care, publishing guidelines that emphasize the assessment of sexual orientation, gender identity, and the impact of minority stress on diabetes outcomes. You can read the ADA’s position on LGBTQ+ care here.

Cultural Competence and Inclusive Care in Primary Care

Inclusive care is not merely about using correct pronouns—it requires a systemic commitment to understanding how stigma and discrimination shape health behaviors and outcomes. Primary care providers are often the first point of contact for patients with new diagnoses of prediabetes or diabetes, making these settings ideal for implementing affirming practices.

Key Components of Affirming Diabetes Care

  • Routine collection of sexual orientation and gender identity (SOGI) data in a confidential manner, using validated questions that allow patients to self-disclose safely.
  • Non-judgmental communication that acknowledges the patient’s full identity, including relationship status, family structure, and support systems.
  • Training for all clinical and administrative staff on LGBTQ+ health topics, including hormone therapy interactions, mental health comorbidities, and culturally sensitive weight management counseling.
  • Visible symbols of inclusion—such as rainbow stickers, Safe Zone signage, or intake forms that include options beyond male/female—to signal a safe space.

When patients feel safe, they are more likely to disclose relevant information, such as the use of testosterone or estrogen, which can directly affect glycemic control. They are also more likely to adhere to follow-up visits and self-management recommendations.

Unique Challenges Experienced by LGBTQ+ Patients with Diabetes

Hormone Therapy and Diabetes Management

Transgender and gender-diverse patients may be on gender-affirming hormone therapy (GAHT) for years. Testosterone therapy in transmasculine individuals can increase insulin resistance and visceral adiposity, potentially raising A1C levels. Estrogen therapy in transfeminine individuals may affect lipid profiles and blood pressure, complicating cardiovascular risk management—a major concern in diabetes. Providers must coordinate endocrinology care and monitor labs more frequently when a patient starts or adjusts hormone therapy.

Mental Health and Minority Stress

Minority stress—the chronic stress experienced by stigmatized groups—disproportionately affects LGBTQ+ individuals and is linked to higher rates of depression, anxiety, substance use, and disordered eating. All of these can interfere with diabetes self-care: missed medications, irregular meal patterns, reduced physical activity, and poorer glucose monitoring. Integrating mental health screening into diabetes visits, using tools like the PHQ-9 or GAD-7, and offering referral to LGBTQ+-affirming therapists can dramatically improve outcomes.

Social Support and Family Dynamics

Many LGBTQ+ patients have chosen families or are estranged from biological relatives. Diabetes education materials often assume a traditional family structure with a supportive spouse or adult children nearby. Providers should ask patients who they consider their support network and involve those individuals in care planning when appropriate. Support groups tailored to LGBTQ+ individuals with diabetes can also be invaluable. The National LGBTQIA+ Health Education Center offers resources for finding affirming community programs.

Discrimination in Healthcare Settings

Reports of discrimination—ranging from misgendering to outright denial of care—remain alarmingly common among LGBTQ+ patients. Such experiences lead to healthcare avoidance, delaying diabetes diagnosis and management. To combat this, primary care practices should adopt zero-tolerance policies for discriminatory behavior and prominently display nondiscrimination statements.

Tailoring Diabetes Management for LGBTQ+ Patients

Medication Considerations

  • Metformin remains first-line therapy for type 2 diabetes, but its gastrointestinal side effects can be problematic for patients on certain hormone regimens that already affect digestion or appetite.
  • GLP-1 receptor agonists (e.g., liraglutide, semaglutide) promote weight loss and cardiovascular protection, but their cost and injection burden may be barriers. Discussing insurance coverage and alternative formulations (oral semaglutide) is key.
  • SGLT2 inhibitors (e.g., empagliflozin) offer renal and cardiac benefits but require counseling on genital hygiene and infection risk—conversations that should be conducted with sensitivity given the patient’s anatomy and sexual practices.
  • Insulin dose adjustments may be needed when starting or changing GAHT, as hormone levels can alter insulin requirements. Frequent glucose monitoring and endocrinology collaboration are recommended.

Nutrition and Lifestyle Counseling

Nutrition advice should be culturally competent and avoid assumptions about diet, body image, or exercise preferences. For example, transgender patients may have specific body composition goals related to their transition that influence their willingness to lose weight. Providers should use a health-at-every-size approach while acknowledging the metabolic benefits of modest weight loss. Exercise recommendations should be inclusive of activities that feel safe—such as solo gym sessions during less busy hours, or at-home workouts—to minimize the risk of harassment.

Reproductive and Sexual Health Considerations

Diabetes affects sexual health: erectile dysfunction, vaginal dryness, and decreased libido are common. LGBTQ+ patients may have different concerns. For lesbian and bisexual women, screening for polycystic ovary syndrome (PCOS) and metabolic syndrome should be standard. For gay and bisexual men, HIV status and use of antiretroviral therapy can affect diabetes risk and management. Providers should ask about sexual activity in a non-heteronormative way and offer appropriate preventive care, including PrEP and HPV vaccination.

Creating a Supportive Clinical Environment

A truly inclusive primary care setting goes beyond individual patient encounters. Systemic changes include revising intake forms to collect gender identity and pronouns in a confidential manner, training front-desk staff on respectful communication, and maintaining a referral network of LGBTQ+-affirming specialists—endocrinologists, dietitians, mental health providers, and even podiatrists.

Consider designating a staff member or a committee as the LGBTQ+ health liaison to oversee these efforts and respond to patient feedback. Regularly conduct patient satisfaction surveys that explicitly ask about inclusiveness, and adjust policies accordingly. The Human Rights Campaign’s Healthcare Equality Index provides a useful framework for evaluating and improving LGBTQ+ inclusive policies; more information is available on their website.

Confidentiality and Privacy

Many LGBTQ+ patients are not out to all their providers, family members, or employers. Electronic health records should allow discrete fields for sexual orientation and gender identity that are not visible to all staff without a clinical reason. Discussing diabetes management with a patient requires assurance that their identity and health data will remain private, especially if they are a minor or live in an unsupportive environment.

Education and Resources

Patient education materials—handouts, videos, and online portals—should reflect diverse bodies, relationships, and experiences. For example, blood glucose monitoring instructions that assume a male body or a female body may not apply to transgender patients. Use diagrams that include variations in anatomy and avoid gendered language.

Consider partnering with community organizations to develop resources. The CDC’s Diabetes and LGBTQ+ Health feature offers practical guidance and links to affirming health services. Additionally, the GLMA: Health Professionals Advancing LGBTQ+ Equality maintains a directory of LGBTQ+-friendly healthcare providers.

Conclusion

Addressing the needs of LGBTQ+ patients with diabetes in primary care requires a multifaceted commitment: from understanding the biological impacts of hormone therapy to dismantling systemic discrimination. By adopting inclusive practices, providing comprehensive education, and tailoring treatment plans to the whole person, primary care providers can reduce disparities and improve health outcomes. Equity in diabetes care is not optional—it is a clinical imperative. When patients from all identities feel seen, respected, and heard, they are empowered to manage their health with confidence and resilience.